Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004979589 | SCV005576944 | uncertain significance | Inborn genetic diseases | 2024-11-25 | criteria provided, single submitter | clinical testing | The c.1195T>C (p.S399P) alteration is located in exon 7 (coding exon 7) of the EIF2AK3 gene. This alteration results from a T to C substitution at nucleotide position 1195, causing the serine (S) at amino acid position 399 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005038894 | SCV005661193 | uncertain significance | Wolcott-Rallison dysplasia | 2024-04-15 | criteria provided, single submitter | clinical testing |